NYSEMKT: AEON
Aeon Biopharma Inc Stock Ownership - Who owns Aeon Biopharma?

Insider buying vs selling

Have Aeon Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jost FischerDirector2025-05-2160,000$0.49
$29.22kBuy
Jost FischerDirector2025-05-2060,000$0.51
$30.36kBuy
Jost FischerDirector2025-05-1950,000$0.50
$24.95kBuy

1 of 1

AEON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AEON insiders and whales buy or sell their stock.

AEON Shareholders

What type of owners hold Aeon Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Priveterra Sponsor LLC122.85%13,889,163$12.65MInsider
Daewoong Co Ltd58.18%6,577,604$5.99MInsider
Robert J. Palmisano20.35%2,301,021$2.10MInsider
Strathspey Crown Holdings Group LLC17.97%2,031,773$1.85MInsider
Dauntless Investment Group LLC9.07%1,025,000$933.78kInstitution
Marc Forth6.64%750,547$683.75kInsider
Barclays PLC6.22%702,645$640.11kInsider
Sabby Management LLC3.98%449,687$409.66kInstitution
Chad Oh2.59%292,545$266.51kInsider
Jost Fischer2.36%266,785$243.04kInsider

1 of 3

AEON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AEON5.29%94.71%Net BuyingNet Buying
APRE3.18%96.82%Net BuyingNet Buying
PSTV1.19%71.44%Net Buying
GLYC30.41%69.59%Net Selling
CYCN11.60%88.40%Net SellingNet Buying

Aeon Biopharma Stock Ownership FAQ

Who owns Aeon Biopharma?

Aeon Biopharma (NYSEMKT: AEON) is owned by 13.50% institutional shareholders, 241.84% Aeon Biopharma insiders, and 0.00% retail investors. Priveterra Sponsor LLC is the largest individual Aeon Biopharma shareholder, owning 13.89M shares representing 122.85% of the company. Priveterra Sponsor LLC's Aeon Biopharma shares are currently valued at $12.65M.

If you're new to stock investing, here's how to buy Aeon Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.